Are there gender differences in the prescribing of hypnotic medications for insomnia?

Human Psychopharmacology

Volumn 18, Issue 1, 2003, Pages 69-73

  Brownlee, K ^a   Devins, G M ^b,c,d   Flanigan, M ^d   Fleming, J A E ^e   Morehouse, R ^f   Moscovitch, A ^g   Plamondon, J ^h   Reinish, L ^d   Shapiro, C M ^c  

^a LAKEHEAD UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f SAINT JOHN REGIONAL HOSPITAL   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antidepressants; Antihistamines; Gender; Insomnia

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; PSYCHOTROPIC AGENT; TRANQUILIZER; ZOPICLONE;

ADULT; AGE; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG USE; EMPLOYMENT; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SEX ROLE; SOCIAL STATUS;

CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH SURVEYS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; SEX FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0037275479     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.452     Document Type: Review

References (16)

1. Ashton H, Golding JF. 1989. Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey. Br J Addict 84: 541-546.
2. Brewin CR. 1984. Perceived controllability of life-events and willingness to prescribe psychotropic drugs. Br J Soc Psychol 23: 285-287.
3. Cafferata GL, Kasper J, Bernstein A. 1983. Family roles, structure and stressors in relation to sex differences in obtaining psychotropic drugs. J Health Soc Behav 24: 132-143.
4. Cafferata GL, Meyers SM. 1990. Pathways to psychotropic drugs: understanding the basis of gender differences. Med Care 28: 285-299.
5. Cooperstock R. 1978. Sex differences in psychotropic drug use. Sci Med 12B: 179-186.
6. Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttman RD. 1983. The emotional impact of end-stage renal disease: the importance of patient's perceptions of intrusiveness and control. Int J Psychiatr Med 13: 327-343.
7. Devins GM, Onne CM. 1985. Centre for epidemiologic studies depression scale. In Test Critiques, 2nd edn, Keyser DJ, Sweetland RC (eds). Test Corporation of America: Kansas; 144-160.
8. Hohmann AA. 1989. Gender bias in psychotropic drug prescribing in primary care. Med Care 27: 478-490.
9. Johns MW. 1991. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540-545.
10. Radlof LS. 1977. The CES-D scale: a self-report depression scale for research in the general population. Appl Psycholo Measure 3: 385-401.
11. Rawson NSB, D'Arcy C. 1991. Sedative-hypnotic use in Canada. Statistics Canada Health Rep 3: 33.
12. Shapiro CM, MacFarlane JG, Hussain MG. 1994. Conquering Insomnia. Empowering Press: Hamilton, Ont.
13. Taggart LAP, McCammon SL, Allred LJ, Horner RD, May HJ. 1993. Effect of patient and physician gender on prescriptions for psychotropic drugs. J Women's Health 2: 353-357.
14. Verbrugge LM, Steiner RP. 1981. Physician treatment of men and women patients: sex bias or appropriate care. Med Care 19: 609-632.
15. Verbrugge LM, Steiner RP. 1985. Prescribing drugs to men and women. Health Psychology 4: 79-98.
16. Wells KB, Kamberg C, Brook R, Camp P, Rodgers W. 1985. Health status, sociodemographic factors, and the use of prescribed psychotropic drugs. Med Care 23: 1295-1306.